Current Status of RWD/E Use in Regulatory Decision Making: Lessons Learned, Ongoing Challenges, and Future Directions
- Review FDA use cases where RWE has supported regulatory submissions and decisions
- Explore therapeutic-area differences in feasibility, fit-for-purpose data, and evidentiary expectations
- Discuss key challenges, lower hanging opportunities, and future directions for RWD/E in regulatory decision-making